Sunshine Act Notice

---
identifier: "/us/fr/05-14678"
source: "fr"
legal_status: "authoritative_unofficial"
title: "Sunshine Act Notice"
title_number: 0
title_name: "Federal Register"
section_number: "05-14678"
section_name: "Sunshine Act Notice"
positive_law: false
currency: "2005-07-25"
last_updated: "2005-07-25"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Tennessee Valley Authority"
document_number: "05-14678"
document_type: "notice"
publication_date: "2005-07-25"
agencies:
  - "Tennessee Valley Authority"
fr_citation: "70 FR 42614"
fr_volume: 70
---


#  Sunshine Act Notice

**Federal Register Citation of Previous Announcement:**

70 FR 41472 (July 19, 2005).

**Previously Announced Time and Date of Meeting:**

9 a.m. (e.d.t.), Friday, July 22, 2005.

**Previously Announced Place of Meeting:**

TVA Knoxville West Tower Auditorium, 400 West Summit Hill Drive, Knoxville, Tennessee.

**Changes in the Meeting:**

The TVA Board of Directors has approved the addition of the following items to the previously announced agenda:

**C—Energy**

C4. Contract with Cameco, Inc., for purchase of uranium concentrates and uranium conversion.

C5. Contract with ConverDyn for purchase of uranium conversion services.

**FOR FURTHER INFORMATION CONTACT:**

Please call TVA Medical relations at (865) 632-6000, Knoxville, Tennessee. Information is also available through TVA's Washington Office at (202) 898-2999.

Maureen H. Dunn,

General Counsel and Secretary of Corporation.